Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/22431
Title: Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.
Author: Vianna, Joao L.
Haga, Hans J.
Tripathi, Poonam
Cervera i Segura, Ricard, 1960-
Khamashta, Munther A.
Hughes, Graham R. V. (Graham Robert Vivian)
Keywords: Lupus eritematós
Síndrome antifosfolipídica
Estudi de casos
Lupus erythematosus
Antiphospholipid syndrome
Case studies
Issue Date: 1992
Publisher: BMJ Group
Abstract: The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work.
Note: Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.51.2.160
It is part of: Annals of the Rheumatic Diseases, 1992, vol. 51, núm. 2, p. 160-161
Related resource: http://dx.doi.org/10.1136/ard.51.2.160
URI: http://hdl.handle.net/2445/22431
ISSN: 0003-4967
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
562698.pdf400.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.